R-CHOP versus dose-adjusted R-EPOCH in frontline management of primary mediastinal B-cell lymphoma: a multi-centre analysis.

R-CHOP versus dose-adjusted R-EPOCH in frontline management of primary mediastinal B-cell lymphoma: a multi-centre analysis. Br J Haematol. 2018 02; 180(4):534-544.

View in: PubMed

subject areas

Adult
Aged
Antibodies, Monoclonal, Murine-Derived
Antineoplastic Combined Chemotherapy Protocols
Combined Modality Therapy
Cyclophosphamide
Disease Management
Doxorubicin
Etoposide
Female
Humans
Lymphoma, B-Cell
Male
Mediastinal Neoplasms
Middle Aged
Neoplasm Grading
Neoplasm Staging
Prednisone
Recurrence
Retrospective Studies
Rituximab
Treatment Failure
Treatment Outcome
Vincristine
Young Adult

authors with profiles

Nirav Shah